1. Home
  2. |Insights
  3. |"Paralyzing Uncertainty" Does Not Create Declaratory Judgment Jurisdiction

"Paralyzing Uncertainty" Does Not Create Declaratory Judgment Jurisdiction

Client Alert | 2 min read | 09.04.08

In Prasco, LLC v. Medicis Pharmaceutical Corporation and Imaginative Research Associates, Inc. (No. 07-1524; August 15, 2008), the Federal Circuit further clarifies the scope of declaratory judgment jurisdiction in patent cases. The Federal Circuit explains that although the Supreme Court found that an actual controversy can exist when there is no apprehension of suit in MedImmune Inc. v. Genentech, Inc., 127 S. Ct. 764 (2007), "it did not change the bedrock rule that a case or controversy must be based on a real and immediate threat of future injury that is caused by defendants - an objective standard that cannot be met by a purely subjective or speculative fear of future harm."

Prasco filed for a declaratory judgment that its benzoyl peroxide cleansing product did not infringe four patents listed on Medicis' competing benzoyl peroxide product. Prasco claimed that although it had not yet begun marketing its product, it had devoted substantial efforts to development and marketing plans and that it suffered "paralyzing uncertainty" from fear that Medicis would sue for patent infringement.

In affirming the district court's dismissal, the Federal Circuit finds Prasco's paralyzing uncertainty argument insufficient, noting that a patentee's marking of its products with applicable patent numbers provides little, if any, evidence that the patentee will ever enforce its patents. Thus, patent marking is irrelevant to the question of an imminent threat of harm sufficient to create an actual controversy. The Court also indicates that although failure to sign a covenant not to sue is a circumstance to be considered, it is not sufficient on its own to create an actual controversy. The Court explains that some affirmative action by patentee is usually necessary to create such a controversy and that a patentee has no obligation to spend the time and money to test a competitor's product nor to make a definitive determination, at a competitor's request, that it will never bring an infringement suit. In fact, where a competitor does approach a patentee with such a request, the patentee's silence does not alone make an infringement action or other interference with the competitor's business imminent and does not confer declaratory judgment jurisdiction.

Insights

Client Alert | 1 min read | 04.18.24

GSA Clarifies Permissibility of Upfront Payments for Software-as-a-Service Offerings

On March 15, 2024, the General Services Administration (GSA) issued Acquisition Letter MV-2024-01 providing guidance to GSA contracting officers on the use of upfront payments for acquisitions of cloud-based Software-as-a-Service (SaaS).  Specifically, this acquisition letter clarifies that despite statutory prohibitions against the use of “advance” payments outside of narrowly-prescribed circumstances, upfront payments for SaaS licenses do not constitute an “advance” payment subject to these restrictions when made under the following conditions:...